RBR-76j763kRecruitingPhase 2
Treatment with Menadione in patients with Gastric Cancer in the Unified Health System
Hospital Ophir Loyola0 sitesStarted: November 9, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 19Y to 0 (—)
Inclusion Criteria
- •Patients with locally advanced (T2, T3 or T4) and/or incurable disease; with a performance status between 0 and 2 according to the criteria defined by the Eastern Cooperative Oncology Group or greater than or equal to 60% by the Karnofsky performance status; with adequate organ and bone marrow functions and left ventricular ejection fraction above 50%
Exclusion Criteria
- •Patients with brain metastases, angina, intestinal obstruction, active gastrointestinal bleeding and an estimated life of less than three months; with clinically significant comorbidities that may interfere with treatment tolerance and efficacy; on warfarin
Investigators
Similar Trials
Active, not recruiting
Phase 1
Menthacarin® in the treatment of functional gastrointestinal disordersCTIS2022-501800-92-00Dr. Willmar Schwabe GmbH & Co. KG120
Recruiting
Phase 3
Ondansetron for symptoms of gastroparesis in patients with chronic kidney disease undergoing hemodialysisGastroparesis in patients with chronic kidney disease.OndansetronGastric accommodationHemodialysisChronic kidney diseaseGastroparesisTCTR20240712001Faculty of Medicine, Chiang Mai University72
Active, not recruiting
Phase 1
Treatment of gastrostomy related granuloma using hydrocortisone or tea tree oil: A randomized controlled trial. - Hydrocortisone versus Tea Tree oil in treating gastrostomy related granulomaEUCTR2007-001810-18-GBniversity Hospital Of North Staffordshire
Active, not recruiting
Not Applicable
A Treatment Protocol for Patients with Gastrointestinal Stromal Tumor who are Ineligible for Participation in Other SU011248 Protocols AND are Refractory to or Intolerant of Imatinib Mesylate.Gastro-intestinal Stromal TumorsMedDRA version: 14.1Level: PTClassification code 10051066Term: Gastrointestinal stromal tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2004-001860-27-ITPFIZER1,098
Not yet recruiting
Not Applicable
Combination therapy of paclitaxel, ramucirumab, and TEW7197 as a secondary treatment for gastric cancerNeoplasmsKCT0005928Samsung Medical Center43